Evercore ISI Group Maintains In-Line on Healthpeak Properties, Lowers Price Target to $22
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsPrice Target
Evercore ISI Group analyst James Kammert maintains Healthpeak Properties (NYSE:DOC) with a In-Line and lowers the price target from $23 to $22.
Evercore ISI Group analyst James Kammert maintains Healthpeak Properties (NYSE:DOC) with a In-Line and lowers the price target from $23 to $22.